Brawn Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results
Brawn Biotech Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Brawn Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results Brawn Biotech Ltd has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited financial results for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the company's trading window for dealing in securities remains closed until 16th Nov'26 and will reopen on 17th Nov'26.
Original exchange filing (PDF)
More announcements from Brawn Biotech Ltd
- Intimation regarding non-applicability of regulation 23(9) 路 05 Nov 2026
- Outcome of Board Meeting 路 05 Nov 2026
- Outcome Of Board Meeting Held On 5th November, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended September 30, 2026. 路 05 Nov 2026
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 路 29 Sept 2026
- Scrutinizers Report attached along with voting results for 41st AGM 路 29 Sept 2026
- Proceedings of 41st AGM 路 29 Sept 2026
- Outcome of 41st Annual General Meeting 路 29 Sept 2026
- Letters sent to shareholders as per Reg 36 路 02 Sept 2026
